WHO Guidelines on Leprosy: Are We Doing Enough?

Leprosy is a curable yet neglected disease that still affects over 200,000 people worldwide each year. The World Health Organization (WHO) provides clear guidelines for early detection, treatment, and prevention, but are we fully implementing them? At Zehntech’s Skin and Aesthetics Clinic, we follow WHO-recommended protocols to ensure compassionate, effective care—under the supervision of the best dermatologist in Indore. 

What Do WHO Guidelines Emphasize? 

1. Early Detection and Diagnosis  Spotting leprosy early minimizes nerve damage and disability. WHO urges routine skin examinations and nerve testing in high-risk areas. 

2. Multi-Drug Therapy (MDT)  Free MDT using Rifampicin, Dapsone, and Clofazimine remains the gold standard. WHO recommends full treatment completion within 6–12 months to prevent relapse. 

3. Stigma Reduction  WHO stresses community education to eliminate the fear and isolation associated with leprosy. 

4. Integrated Care  Treatment should be combined with rehabilitation, counseling, and physical therapy, especially for those with advanced symptoms. 

Where We Fall Short 

Despite global guidelines, many regions still struggle with delayed diagnosis, social stigma, and lack of access to specialized care. That’s where expert-led programs—like those at our skin clinic—bridge the gap. 

At we combine WHO protocols with personalized, empathetic care. Our commitment extends beyond medicine—we aim to restore confidence, mobility, and dignity.